Renu Chawla, MD
Internal Medicine · Bellevue, WANPI 1285634790
Payments from drug & device makers
Across 26 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$209
- Kowa Pharmaceuticals America, Inc.$79
- Boehringer Ingelheim$57
- Johnson & Johnson$22
- Amarin Pharma, Inc.$20
- GSK$20
- plus $73 from 5 others
What the payments were for
- Food & beverage$479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $209 |
| Kowa Pharmaceuticals America, Inc. | 5 | $79 |
| Boehringer Ingelheim | 3 | $57 |
| Johnson & Johnson | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $20 |
| GSK | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $17 |
| Boston Scientific | 1 | $17 |
| AstraZeneca | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Pfizer | 1 | $11 |
How this compares
$479 in reported general payments places this provider in the 80th percentile of 2,038 internal medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $20,383 |
| Lidocaine | 15 | $2,222 |
| Rosuvastatin Calcium | 89 | $2,155 |
| Esomeprazole Magnesium | 22 | $1,824 |
| Atorvastatin Calcium | 175 | $1,778 |
| SynthroidLevothyroxine Sodium | 21 | $1,517 |
| Levothyroxine Sodium | 123 | $1,406 |
| Gabapentin | 61 | $1,196 |
| Amlodipine Besylate | 115 | $1,066 |
| Duloxetine Hcl | 24 | $959 |
| Estradiol | 12 | $758 |
| Azelastine Hcl | 16 | $731 |
| Omeprazole | 45 | $644 |
| Losartan Potassium | 73 | $594 |
| Olmesartan Medoxomil | 18 | $588 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bellevue
- Lawrence LoebBellevue$784K
- Gary SchusterBellevue$16K
- Allen GeltzerBellevue$14K
- Tatyana KutsyBellevue$13K
- Sabrina BenjaminOlympia$7.9M
- Ryan AhernSeattle$7.3M
- Eric KleinOlympia$2.4M
- Scott RamseySeattle$2M
- Vidya MenonTacoma$1.8M
- Peter ShalitSeattle$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.